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A longitudinal analysis of CAM use and CPPD. 
  
Cyclic perimenstrual pain and discomfort and Australian women’s associated use of complementary and 
alternative medicine: a longitudinal study. 
 
Abstract 
Objective 
To examine the longitudinal change in Australian women’s prevalence of cyclic perimenstrual pain and discomfort and 
the association between their symptoms and use of complementary and alternative medicine (CAM). 
Method 
Data on endometriosis, premenstrual syndrome (PMS), irregular periods, heavy periods and severe period pain were 
collected over a seven-year period from the Australian Longitudinal Study on Women’s Health, for women aged 28 to 33 
years in 2006, and at three year follow-ups.  Changes in symptoms and patterns of CAM practitioner and 
therapy/product use associated with these symptoms were analysed using longitudinal regression modelling. 
Results 
Over the seven-year period, prevalence rates of PMS and heavy periods increased, whilst prevalence rates of 
endometriosis, irregular periods, and severe period pain remained stable. The most common use of CAM longitudinally 
associated with the perimenstrual symptoms were use of vitamins/minerals, yoga/meditation, massage therapy, herbal 
medicine and aromatherapy.  
Excluding consultation with a naturopath/herbalist, over the 7-year survey women’s use of all other CAM practitioners 
increased as did their use of vitamin/minerals, yoga/meditation and Chinese medicines, whilst aromatherapy use 
declined. 
Conclusion 
Only the prevalence of PMS and heavy periods increased with aging in this sample of women. Whilst overall use of CAM 
practitioner and self-prescribed products/therapies increased over time, CAM was chosen by women mainly to treat 
endometriosis and PMS. The extent to which this use reflects treatment efficacy is uncertain. 
Keywords: endometriosis, premenstrual syndrome, irregular periods, heavy periods, severe dysmenorrhoea, 
complementary and alternative medicine, longitudinal study.  
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Introduction 
In 2002 the Association of Women’s Health, Obstetric and Neonatal Nurses organized the diverse symptoms associated 
with perimenstrual symptoms into the concept of cyclic perimenstrual pain and discomfort (CPPD).1 This term 
encompasses a cluster of symptoms commonly experienced by many women which were  treated as single menstrual 
issues, predominantly premenstrual syndrome (PMS) and dysmenorrhoea.1  It is now well established that between 80-
97% of women experience at least one CPPD symptom between ages 12-50 years. 2, 3 For some 40% of women the 
symptoms are moderate2, for up to 10% they are severe enough to interfere with normal educational, professional 
and/or social functions according to their menstrual cycles.3 These life-changing disadvantages have serious 
ramifications for a minority of women.3-6 Symptoms of CPPD, estimated to number over 300, may be ‘affective’ 
(emotional/mental such as irritability, anxiety and depression), physical (commonly breast tenderness, bloating, 
headache and cramping) or a combination.1, 7 Symptom patterns may vary in nature, frequency, severity and/or over 
time for each woman. Whilst disturbances in sex hormones and their effect on neurotransmission are implicated, no 
single aetiology satisfactorily explains all CPPD manifestations.2, 5, 8   
Complementary and alternative medicine (CAM) is broadly defined by the World Health Organisation as those therapies 
not routinely taught or used in conventional medical settings.9 CAM use has increased world-wide10, 11 with women 
identified as predominant users.12-14 Conventional medical treatment for CPPD is wide-ranging and symptom-related, 
encompassing pharmaceutical, surgical and psychological treatments, none of which are wholly effective alone or in 
combination1, 7, benefitting up to  60% of sufferers.15 Indeed, studies consistently indicate that most women with CPPD 
seek no medical help.16-18 At the same time various CAM clinical trials have reported benefits in  CPPD treatment 
including herbal medicine for PMS19, 20 and acupuncture21 and herbs for dysmenorrhoea.22 Data from 20 cross-sectional 
studies conducted since 2007 indicate prevalence of CAM use for CPPD of between 7-70% (mean=30%).17, 23-41 Whilst 
these studies represent a significant increase in research into CAM use for CPPD, the data lack coherence due to 
enormous variations in design and methodology. Additionally, few studies have tracked changes in CPPD symptoms with 
aging and to-date none have examined CAM use over time amongst women experiencing CPPD. This present study 
initiates the process of analysing age-related changes in CPPD and associated changes in CAM use, an important but 
under-studied area of research. 
Materials and Methods 
Sample 
The Australian Longitudinal Study on Women’s Health (ALSWH), initiated in 1996, aimed to assess and monitor women’s 
health, including their health-seeking behaviour using surveys conducted at 3-yearly intervals. Over 58,000 women in 
three age groups (‘young’, 18-23 years; ‘mid-age’, 45-50 years; ‘older’, 70-75 years) were randomly selected from the 
national Medicare database and invited by mail to participate. The current analysis was based on the ‘young’ cohort of 
women, born between 1973 and 1978, as they represented women in the middle of the menstruating period of their 
lives.  The baseline response rate for this cohort of 41-42% was estimated, due to uncertainty over the original Medicare 
database’s accuracy42, however the demographic profile indicated responders were a  representative sample when 
compared to 1996 census data.43  Data from surveys 4, 5 and 6, conducted in 2006, 2009 and 2012 respectively, 
obtained via questionnaires, were analysed. The response rates over the three surveys were 68% (n=9145) for survey 4 
and 62% (n=8200) for surveys 5 and 6 (n=8010).  
Ethical approval for the ALWSH was granted by the Human Ethics Committee at the University of Queensland and 
University of Newcastle and written consent was obtained from all participants. 
Cyclic Perimenstrual Pain and Discomfort (CPPD) symptoms 
Questions to participants included being diagnosed with endometriosis in the previous 3 years and the frequency of 
experiencing the following undefined conditions, premenstrual tension, irregular periods, heavy periods and severe 
period pain for 12 months prior to each survey, using the grades ‘never’, ‘rarely’, ‘sometimes’ or ‘often’.  The term 
‘premenstrual tension’ has been used consistently in these surveys, its original reference relating to emotional changes 
that occurred prior to menstruation. ‘Premenstrual syndrome’, suggested in 1953 to take into account the physical and 
behavioural changes that also occur at this time, is the current terminology.44 
Complementary and alternative medicine (CAM) use 
In each survey, for the previous 12 month period, women were asked to respond to the question of whether they had 
consulted with a chiropractor, osteopath, massage therapist, acupuncturist and/or naturopath/herbalist for their own 
health. Participants were also questioned about CAM therapy and products used for their own health in the previous 12 
months. Specific categories listed were ‘vitamins/minerals’, ‘yoga/meditation’, ‘herbal medicines’, ‘aromatherapy oils’ 
and ‘Chinese medicine’; with answers graded by frequency of use as ‘never’, ‘rarely’, ‘sometimes’ or ‘often’.   
 
Confounders 
The demographic factors ‘area of residence’, ‘educational status’, ‘ability to manage on income’ , ‘marital status’, ‘body 
mass index’ (BMI)  calculated from height and weight, without shoes, ,’ parity’ based on live births, ‘stress’, ‘exercise 
level ’ , ‘contraceptive use’ (oral and/or implant) and ‘ethnicity’  as well as the co-morbidities ‘insulin-dependent (Type 
1) diabetes ’, ‘non-insulin dependent (Type 2) diabetes’, ‘low iron (iron deficiency or anaemia)’, ‘depression’, ‘anxiety 
disorder’, ‘asthma’  and ‘hypertension (high blood pressure)’ were ascertained from the survey and identified as 
potential confounders. All co-morbidities were coded in the affirmative if diagnosed or treated in the previous 3 year 
period. Women who had been diagnosed with cancer in the previous three years, totalling 261 over the three surveys, 
were excluded from all analyses as the disease and/or its treatment may have affected symptom reporting and CAM 
use. 
Area of residence was categorised as either urban or rural. Educational status was categorised as: (1) ‘No formal 
qualifications’/’Year 10 or equivalent (e.g. School Certificate)’/ ’Year 12 or equivalent (e.g. Higher School Certificate)’; (2) 
‘Trade / apprenticeship’/ ‘Certificate/diploma’; and (3) ‘University/Higher university degree’.  Ability to manage on 
available income was categorised as: (1) ‘It is impossible’/’It is difficult all of the time’; (2) ’It is difficult some of the 
time’; and (3) ‘It is not too bad’/’It is easy’. Marital status was categorised as: (1) ‘Never married’; (2) ‘Married/De facto 
(opposite and same sex)’; and (3) ‘Separated/Divorced/Widowed’.  BMI was categorised as: 
1)’<18.5kg/m2’(underweight); (2) ‘18.5-<25.0kg/m2’ (normal); (3) ‘=>25-<30 kg/m2’(overweight); (4) ‘=>30 
kg/m2’(obese). Parity was categorised as: (1) ‘none’; (2) 1-2; (3) 3 or more.  The mean stress level, defined, validated and 
calculated by ALSWH, based on stress felt in the last 12 months around 11 life domain items was categorised as: (1) ‘Not 
applicable/Not at all stressed’; (2) ‘Somewhat stressed’; (3) ‘Moderately stressed’; (4) ‘Very stressed’; (5) ‘Extremely 
stressed’. Level of exercise was calculated using an algorithm based on time in last week spent in ‘Walking briskly’, 
‘Moderate leisure activity’ and ‘Vigorous leisure activity’ data, derived from Active Australia’s National Physical Activity 
Survey, categorised as: (1) ‘Sedentary’; (2) ‘Low’; (3) ’Moderate’; (4) ‘High’. Current contraceptive use had a binary code, 
based on a positive response to any of the following, ‘I use the oral contraceptive pill’ (survey 4) and ’I use a combined 
oral contraceptive pill’/I use a progestogen only oral contraceptive pill/I use the oral contraceptive pill but I don’t know 
what type’ (surveys 5 &6) and/or ‘I use an implant’ (all surveys).  Ethnicity was categorised according to country of birth 
as: (1) ‘Australia’; (2) ‘Other English speaking background’; (3) ‘Europe’; (4) ‘Asia’ (excluding the Middle East); (5) ‘Other’. 
 
 Statistical Analysis 
Longitudinal regression modelling was conducted using generalised estimating equations (GEEs). GEEs are an extension 
of generalised linear models that allow for the analysis of data longitudinally, thus reflecting the relationship between 
the longitudinal development of the association between CPPD symptom and CAM practitioner or CAM therapy use in 
non-pregnant respondents over the different survey timeframes, taking into account the significant confounding 
variables identified. Analyses were achieved using the statistical package STATA 14.0 and due to the large sample size, 
statistical significance was set at p < 0.005. The Wald statistic was used to assess the fit of the multivariable models.  
No interactions were examined. 
 
Results 
The prevalence rates for endometriosis (mean = 4.0%), irregular periods (mean = 20.9%) and severe period pain (mean = 
23.7%) recorded over the three surveys appeared largely unaffected by age change (Table 1). Prevalence of PMS was 
highest in 2012, averaged 36.0% between 2006 and 2009 and rose to 41.4% in 2012. Similarly, the prevalence of heavy 
periods showed little change between 2006 and 2009 (mean = 22.8 %) but increased to 29.9% by 2012. 
 
All multivariate analyses were adjusted for co-morbidities of diabetes, hypertension, anaemia, asthma, depression, and 
anxiety and for demographics of area of residence, marital status, educational status, ability to manage on income, 
body-mass index, parity, stress, exercise level, oral/implant contraceptive use and ethnicity. Over the seven year time 
period women with endometriosis were more likely to have consulted with a massage therapist (OR=1.26; 95% CI: 1.08, 
1.47), nearly twice as likely to have consulted with an acupuncturist (OR=1.88; 95% CI: 1.51, 2.35) and over 50% more 
likely to have consulted a naturopath/herbalist (OR=1.54; 95% CI: 1.26, 1.88), compared to women who had not been 
diagnosed with endometriosis (Table 2).  
Statistically significant associations were found between PMS and consultation with a naturopath/herbalist only. 
Specifically, these consultations were more likely for women who sometimes (OR=1.23; 95% CI: 1.09, 1.40) or often 
(OR=1.48; 95% CI: 1.27, 1.74) suffered PMS, compared to non-sufferers (Table 2). 
Women who had irregular periods were no more likely to have consulted with any CAM therapist compared to those 
who never had irregular periods whilst those who often had heavy periods were less likely to consult with an osteopath 
(OR=0.64; 95% CI: 0.49, 0.83) compared to those who never had heavy periods.  Women who sometimes had severe 
period pain were less likely to consult with a naturopath/herbalist (OR=0.78; 95% CI: 0.67, 0.91) than those women who 
reported they never had this symptom. 
The likelihood that any woman consulted with a CAM practitioner increased from 2006 to 2009 for a chiropractor 
(OR=1.25; 95% CI: 1.15, 1.36), an osteopath (OR=1.64; 95% CI: 1.42, 1.90), a massage therapist (OR=1. 36; 96% CI: 1.27, 
1.46) and/or an acupuncturist (OR=1.84; 95% CI: 1.59, 2.12). In 2012, across the cohort, the likelihood of CAM 
practitioner consultation increased for a chiropractor (OR=1.28; 95% CI: 1.17, 1.41), an osteopath (OR=1.71; 95% CI: 
1.48, 1.98), a massage therapist (OR=1.41; 95% CI: 1.30, 1.52) and/or an acupuncturist (OR=1. 59; 95% CI: 1.37, 1.85) 
compared to 2006 data. The prevalence data for use of CAM practitioners by women with CPPD in 2012 showed that a 
chiropractor, an osteopath, a massage therapist, an acupuncturist and a naturopath/herbalist had been visited by 0.9%, 
0.4%, 1.9%, 0.6% and 0.7% respectively by women with endometriosis; 8.4%, 3.8%, 18.8%, 4.3% and 5.8%  respectively 
for women who sometimes or often had PMS;  4.8%, 1.7%, 10.0%, 2.2% and 3.1%, respectively for those who 
sometimes or often had irregular periods; 5.8%, 2.5%, 12.5%, 2.8% and 4.0% respectively  for those who sometimes or 
often suffered heavy periods and 4.8%, 2.2%, 10.4%, 2.6% and 3.1% respectively for those who sometimes or often 
reported painful periods (Table 3). 
Women with endometriosis were significantly more likely to have used vitamins/minerals (OR=1.40; 95% CI: 1.17, 1.67), 
yoga/meditation (OR=1.35; 95% CI: 1.13, 1.60), herbal medicines (OR=1.34; 95% CI: 1.13, 1.60) and Chinese medicines 
(OR=1.99; 95% CI: 1.53, 2.58) compared to those without endometriosis (Table 4).  
Compared to never sufferers of PMS those who rarely had symptoms were more likely to use herbal medicines 
(OR=1.21; 95% CI: 1.09, 1.34), with the likelihood increasing for sometimes sufferers (OR=1.33; 95% CI: 1.21, 1.48). 
Women who reported they sometimes experienced PMS were also more likely to have used yoga/meditation (OR=1.16; 
95% CI: 1.05, 1.28) and aromatherapy (OR=1.26; 95% CI: 1.14, 1.40) than those who never had PMS. Most CAM 
therapies/products were more likely to be used by women who reported having PMS often compared to those who 
never suffered; specifically vitamins/minerals (OR=1.21; 95% CI: 1.08, 1.37), yoga/meditation (OR=1.27; 95% CI: 1.12, 
1.45), herbal medicines (OR=1.48; 95% CI: 1.30, 1.69), and/or aromatherapy (OR=1.26; 95% CI: 1.11, 1.44). 
Women who indicated sometimes or often having had irregular periods or heavy periods were not more or less likely to 
use any CAM therapies/products. Women who often suffered severe period pain were more likely to use aromatherapy 
(OR=1.34; 95% CI: 1.13, 1.58) compared to those who had not suffered from severe period pain. 
From 2006, for all women, the likelihood increased in 2009 and 2012 of using vitamins/minerals (OR=1.21; 95% CI: 1.13, 
1.31) and (OR=1.26; 95% CI: 1.15, 1.37) respectively, yoga/meditation (OR=1.15; 95% CI:1.05,1.26) and (OR=1.21; 95% 
CI:1.10,1.32) respectively and Chinese medicines (OR=1.61; 95% CI: 1.35, 1. 93) and (OR=1.49; 95% CI: 1.24, 1.79) 
respectively. Herbal medicine use increased slightly in 2009 only, when compared to 2006 (OR=1.17; 95% CI:1.08, 1.28). 
However, for aromatherapy this likelihood decreased in 2009 (OR=0.83; 95% CI: 0.76, 0.90) and declined still further in 
2012 (OR=0.70; 95% CI: 0.64, 0.77), compared to 2006. Prevalence data showed that vitamins/minerals, yoga 
/meditation, herbal medicines, aromatherapy and Chinese medicines were used by 2.9%, 1.3%, 1.1%, 0.7% and 0.4% 
respectively by women with endometriosis. For those women who sometimes or often had PMS the respective 
prevalences of use were 29.7%, 10.9%, 10.2%, 8.3% and 2.7%; for those who sometimes or often had irregular periods 
these were 15.8%, 5.5%, 5.3%, 4.0% and 1.6%; for those who sometimes or often suffered heavy periods these were 
20.9%, 7.1%, 7.2%, 5.8% and 1.8% and for those who sometimes or often reported painful periods these were 17.3%, 
6.2%, 6.2%, 5.4% and 1.6% (Table 5). 
Discussion 
Our study, based on a large, representative sample of young Australian women, was the first as far as we are aware, to 
have analysed changes of CAM use in relation to various menstrual problems spanning the age range from 28-33 years 
through to 34-39 years.  CAM use by women suffering CPPD reflected the general growth in interest and information 
regarding CAM, much likely derived from non-professional sources45, over a seven year timeframe and represents 
important data for health care providers and policy makers.46 
Our findings confirmed the high prevalence and consequent significance of CPPD for women’s health previously 
reported.1, 3, 47 Data from our young cohort, aged over the seven year time–frame, represent a valuable insight into 
possible changes in CPPD with age during this relatively young period of women’s lives but  as previous studies have 
largely employed longer time frames corroboration awaits further research. 
Prevalence of CPPD 
Across 2006 to 2012 the consistent prevalence of endometriosis (mean=4.0%) accords with a reported level of 4.8%46, 
however the choice for a diagnosis made in the previous 3 years rather than the currently accepted 5-year span  may 
have under-estimated its prevalence and may complicate comparisons. Whilst not equivocal the relationship between 
increasing age and endometriosis according to recently published data suggest no correlation exists.48   
Our cohort’s prevalence of irregular periods (mean=20.9%) accorded with a reported level of 25.6%49 again showing no 
consistent age-related trend. Menstrual cycle irregularity may decrease with age49 although a large European study 
found a consistent  prevalence across age groups, rising after 42 years of age, around peri-menopause.50  
Severe dysmenorrhoea levels over the three surveys in our study appeared unaffected by aging, the mean=23.7% 
compared to 2-29%  previously reported.51  Dysmenorrhoea has a high prevalence in under 30-year olds usually 
diminishing with age.51 Variations in definition of ‘severity’, (‘interfering with daily activity or efficiency’52, ‘activity 
inhibited and lack of relief from analgesics’6, ‘absenteeism from work’53)  and reliance on subjective pain assessment 
complicates comparisons across studies relating age to dysmenorrhoea severity.51 In addition, the scant published data 
on severe dysmenorrhoea reported largely on younger women than our cohort. Nevertheless,  factors such as parity, 
age at menarche, lifestyle and weight appear to be significant determinants of changes in dysmenorrhoea, prevalence 
being age-related for women under 30 years old, a group mostly younger than our cohort.52, 6, 54, 55 A longitudinal US 
study into dysmenorrhoea in women comparable in age with our cohort estimated severe dysmenorrhoea prevalence at 
2%, and whilst it declined with age, again parity was a more significant factor.52  
With regard to prevalence of heavy periods, a systematic review estimated this ranged between 10-30%56, consistent 
with our mean of 25.2%. We found menorrhagia prevalence increased with age,  supported by a French College of  
Obstetricians and  Gynaecologists guideline review suggesting a prevalence peak of 24%  in women aged 36-40 years.57  
Pooled data from a systematic review of PMS prevalence, averaged it at 47.8%,  albeit with an extremely broad range 
(10 -98%).58 This average is higher than that found in our surveys, 2006 and 2009, but comparable with the 41.4% 
reported by the 2012 survey. Scant current prevalence data exists relating PMS to ageing but reported  patterns of 
higher PMS levels with age59, 60 and a recent, large general population study of UK women aged 12-50 years having a 
peak prevalence in the 35-39 year age-group61 support our observed age increase.  
CAM use and CPPD  
Over time, our study found women with endometriosis may have been more likely to visit a massage therapist, an 
acupuncturist and/or a naturopath/herbalist and with the exception of aromatherapy, may also have been more likely 
to have used all CAM and in particular Chinese medicine, compared to those without endometriosis. Scientific validation 
exists for benefits from acupuncture62 and Chinese herbal medicine63, 64 in treating pain and poor fertility associated 
with endometriosis, but none to-date for therapeutic massage or naturopathic/western herbalist treatment. However a 
small cross-sectional study into endometriosis associated leg pain found 79%, 67% and 50% of women using massage, 
acupuncture and herbs respectively reported improvement in pain level.26     
From our analysis, women with PMS appeared more likely, over time, to visit a naturopath/herbalist compared with 
non-sufferers.  Compared to non-sufferers of PMS, women who sometimes experienced PMS were also more likely 
users of yoga/meditation, herbal medicine or aromatherapy, but those often suffering PMS increased their use of all 
CAM self-help therapies and products surveyed except Chinese medicines. CAM  clinical trials have indicated 
supplements (calcium, magnesium65 and fish oils 66 ), herbs (Vitex agnus castus)65,  yoga67 and aromatherapy 
(lavender)68 are potentially helpful for PMS. Whilst evidence exists that Chinese herbal medicine may be beneficial 69 ,  
users of this CAM with PMS  in our study were too few to indicate a significant association. General support for the 
efficacy of CAM in treating PMS has been reported in previous surveys where between 37-97% women estimated an 
improvement in symptoms.70-74  Indirect support for individual CAM modalities in PMS treatment  exists from cross-
sectional studies where women reported using osteopathy74, chiropractic74, vitamins/minerals39, 70-73, 75-77, massage29, 70, 
75, 76, yoga/meditation70, 76, Chinese herbs72, acupuncture72, aromatherapy72 and western herbs39, 72, 76 for symptom relief. 
More research into these CAM as treatment approaches appears warranted.  
No published clinical evidence relates efficacy of CAM treatment to irregular periods, although national Taiwanese 
health database records cited ‘menstruation disorders’ amongst the main reasons for prescribing Chinese herbal 
medicine.78 Our study found no positive association of CAM use with irregular menses or heavy periods. The physical 
and social discomfort associated with heavy periods may account for the reduced likely visit of women who often 
experience them to an osteopath, with a non-significant trend away from other forms of CAM that require particular 
dress codes and/or need for personal interaction such as massage therapy, chiropractic, acupuncture and yoga/ 
meditation. Previous studies on women with self-reported menorrhagia79 and/or gynaecological problems associated 
with heavy bleeding including general pelvic problems24 and  fibroids31,36, 37, 80, found an associated use of a variety of 
CAM including herbs, acupuncture, dietary supplements and Chinese medicine. Our analyses did not reflect this. 
The relative lack of CAM use by those in our cohort with either irregular periods and/or heavy periods may be due to 
lack of knowledge in Australia about their potential benefits as in countries where CAM is part of mainstream health 
provision, such as Taiwan and Korea, there is a strong traditional use and acceptance of Chinese medicine to treat these 
problems.33, 47 In addition, unlike PMS and dysmenorrhoea which occur commonly, both cycle irregularity and 
menorrhagia may be perceived as having potentially serious underlying pathologies81, 82 and/or consequences for 
conception and vitality for which diagnosis and treatment are regarded as more appropriately dealt with through 
conventional medicine.  
Scientific evaluation of CAM for dysmenorrhoea is sparse, but support does exist for  yoga83, herbs84 , aromatherapy22  
and Chinese herbal medicines.27, 85 Cross-sectional studies suggest women use vitamins and minerals17, 24, herbs17, 24, 30, 32, 
33, 41, 47 and massage28, 40 regardless of scientific validation. Our study showed no associated CAM use by women with 
dysmenorrhoea except an apparent reduction in association between dysmenorrhoea sometimes experienced and visits 
with a naturopath/herbalist.  This finding contrasted with more widespread CAM use for endometriosis sufferers 
because although dysmenorrhoea is a predominant symptom it is secondary to the disease whereas primary 
dysmenorrhoea may be normalised in menstruation and therefore tolerated16 and/or treated using non-CAM self-help 
remedies such as hot drinks, heat and exercise.17, 24, 40, 70 The only CAM therapies and products associated with 
dysmenorrhoea experienced often was the use of aromatherapy, a practice for which some clinical evidence exists.86  
Regular, monthly severe pain relief may be considered too expensive for regular CAM practitioner treatment and given 
its uncertain aetiology self-treatment with a wide-range of both non-pharmacological and pharmacological strategies is 
known to commonly occur.16, 72  
Prevalence of CAM use   
From 2006 to 2012 the significant increased visits to a chiropractor, an osteopath and an acupuncturist, by all women in 
our study, may relate to their subsidized coverage by Medicare and private health insurers to which an increasing 
number of Australians have subscribed.87, 88 Referrals from medical practitioners to osteopaths, chiropractors, 
acupuncturists and massage therapists88, 89, the relative decreased cost from 2007 to 2012 for chiropractor visits87, 
increased practice of both acupuncture and massage therapy by medical  professionals88,90 and the high accessibility of 
massage therapists who far outnumber other CAM therapists91 are also likely to have increased their uptake.  
Over the study period visits decreased overall by 13% to a naturopath/herbalist, a practitioner-based CAM requiring 
either private health insurance or out-of-pocket funding in Australia and for which over-the-counter products are easily 
self-prescribed. Against this background, women with endometriosis and/or PMS in our study were more likely to have 
increased their visits to a naturopath/herbalist compared to women not suffering these symptoms, strongly suggesting 
significant treatment benefits associated with women receiving this professional guidance. An anomalous UK finding 
noting prescription-related PMS diagnoses by general practitioners decreased four-fold between 1993-1998, whilst PMS 
was the second most common condition treated by UK herbalists in 1998, led its authors to suggest women were by-
passing conventional medicine in favour of CAM treatment.92 An updated survey showed levels of conventional 
prescriptions in the UK for CPPD-related problems were still declining 61,indicating women may be continuing to self-
treat or to seek help beyond conventional medicine. It is possible that herbal medicine has been an effective option for 
PMS, explaining its increased uptake. Whilst aromatherapy use declined substantially over the timeframe of our study, 
this was not mirrored by women suffering PMS, suggesting it too may be an effective treatment. Clearly more research 
is needed into the role of these CAM in PMS treatment. 
According to data from our study, the use of self-prescribed CAM was higher than the use of CAM practitioner services, 
behaviour identified elsewhere.13,76,78 Chinese medicine practitioners’ registration by the Australian government in 
200593, officially ‘recognising’ this modality, may explain our finding that Chinese medicine use increased. 
Acupuncture use is possibly under-reported in our data. Two-thirds of Chinese Medicine Board of Australia registered 
practitioners use acupuncture with Chinese herbal medicine, a category not identified in ALSWH surveys. Additionally 
other practitioners such as osteopaths,  chiropractors, medical doctors and physiotherapists also administer 
acupuncture but may have been unidentified by survey respondents  as acupuncture-orientated visits.94 
Health policy implications 
CAM use is higher amongst chronic ill-health sufferers, women and those whose medical problems are not well 
addressed by conventional treatment.95 Women suffering CPPD clearly satisfy these criteria and are likely to continue 
using CAM. Medical reviews acknowledge that CPPD treatment is largely functional or symptomatic relying on hormone 
replacement therapy, surgery, angiogenesis inhibitors, immune modulators, anti-depressants and/or analgesics with 
limited efficacy, possible side-effects and most importantly perhaps, for this cohort, are often unsuitable for women 
intending to conceive.96, 97 Over 300 treatment strategies are currently offered by conventional health practitioners for 
CPPD indicating their complexity and individual nature.7, 92 At the same time traditional Chinese27, 78 and Western 
conventional medical practitioners recommend CAM such as vitamin B6, herbal, homeopathic and nutritional 
supplements, to their CPPD patients.70, 72, 92, 98 It is therefore in the interest of women, health providers and health policy 
makers to investigate the role of CAM in this significant area of women’s health.  
Study limitations 
When interpreting these study findings, readers should be mindful of some limitations. Whilst the demographic profile 
of ‘young’ age participants initially recruited by ALWSH was considered representative when compared to 1996 
consensus data it is possible, due to the relatively poor retention rate from the original sample, that some bias has been 
introduced and that our cohort may be viewed as unrepresentative thereby reducing the generalizability of our results 
and possibly distorting prevalence of CPPD data and the associated CAM use.  Retrospective reporting by ALSWH 
participants regarding both CPPD symptoms and CAM use raises possible recall bias. Reporting of CPPD symptoms was 
subjective and the lack of standardised instruments and CAM terminology in the surveys may have resulted in 
classification errors and difficulties in cross study comparisons. In particular PMS was used interchangeably with PMT 
which may have led to its under-estimation or incorrect classification.  Also, the use of other contraceptive devices and 
medications that could potentially alter menstrual symptoms could not be assessed as these data were not collected. 
Some response bias is recognised in baseline recruitment because women with tertiary education were over-
represented and some ethnic groups under-represented. Due to lack of relevant data the study was unable to track 
direct changes in CPPD symptoms after CAM use. However, the large, representative sample and data tracking this 
important timeframe in women’s reproductive lives provide strong support for the validity of our findings.  
Conclusion 
Large numbers and proportions of women suffer CPPD with prevalence of PMS and heavy periods apparently increasing 
with age. This study demonstrates many women with CPPD symptoms are self-medicating, using a range of CAM, 
possibly without professional oversight. Increasing use of specific CAM by women with CPPD from 2006 to 2012 
suggests some CAM has untapped potential to significantly benefit these prevalent, disruptive health problems. Given 
the large cost to women, their families and society it is important for health carers and policy makers to gain 
information into the types of alternative treatments being adopted, their efficacy and risk factors. CAM is a promising 
area of treatment for chronic CPPD and there is much to be gained by further research. 
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 Table 1. The Prevalence of Menstrual Problem in non-pregnant women in 2006, 2009 and 
2012. 
  
  
Menstrual Problem 
 
Survey 4 (2006) 
(n=9145) 
 
Survey 5 
(2009) 
(n=8200) 
 
Survey 6 
(2012) 
(n=8010) 
    
Endometriosis    
Sample size 7704 6835 7340 
Prevalence (%) 3.8 4.4 3.7 
PMS    
Sample size 8105 7286 7426 
Prevalence (%) 36.9 35.0 41.4 
Irregular periods    
Sample size 8109 7267 7429 
Prevalence (%) 21.1 19.3 22.2 
Heavy periods    
Sample size 8108 7267 7438 
Prevalence (%) 23.1 22.5 29.9 
Severe period pain    
Sample size 8117 7279 7436 
Prevalence (%) 24.7 22.2 24.2 
 
 
 
PMS – premenstrual syndrome. 
**PMS (premenstrual syndrome) - the emotional, physical and behavioural changes that occur in the luteal phase of menstruation and which subside with the onset of, or after, 
menstruation.  
 
Table 2. The odds ratio* for association of cyclic perimenstrual pain and discomfort and consultations with complementary and alternative 
medicine  practitioners. 
 
Cyclic Perimenstrual Pain and 
Discomfort Symptom 
 
Chiropractor 
 
Osteopath 
 
Massage Therapist 
 
Acupuncturist 
 
Naturopath/herbalist 
 
Odds Ratio (C.I.) 
(n=9719) 
 
Odds Ratio (C.I.) 
(n=9716) 
 
Odds Ratio (C.I.) 
(n=9717) 
 
Odds Ratio (C.I.) 
(n=9717) 
 
Odds Ratio (C.I.) 
(n=9716) 
Endometriosis 
No (reference) 
Yes C,D,E 
 
1.00 
1.21 (1.01,1.43) 
 
1.00 
1.13 (0.86,1.48) 
 
1.00 
1.23 (1.07,1.43) 
 
1.00 
1.97 (1.59,2.44) 
 
1.00 
1.54 (1.27,1.87) 
PMS** 
Never (reference) 
Rarely 
Sometimes C,E 
Often C,E 
 
1.00 
1.03 (0.93,1.13) 
0.97 (0.89,1.07) 
0.95 (0.84,1.08) 
 
1.00 
1.14 (0.98,1.32) 
1.02 (0.88,1.19) 
1.27 (1.04,1.54) 
 
1.00 
1.11 (1.02,1.19) 
1.14 (1.06,1.23) 
1.25 (1.12,1.38) 
 
1.00 
1.07 (0.93,1.25) 
1.11 (0.96,1.28) 
1.28 (1.07,1.55) 
 
1.00 
1.15 (1.02,1.31) 
1.30 (1.15,1.47) 
1.60 (1.38,1.86) 
Irregular cycle 
Never (reference) 
Rarely 
Sometimes E 
OftenE 
 
1.00 
0.94 (0.85,1.04) 
1.08 (0.98,1.21) 
0.95 (0.83,1.08) 
 
1.00 
1.00 (0.85,1.18) 
0.91 (0.76,1.09) 
1.03 (0.84,1.26) 
 
1.00 
0.95 (0.87,1.03) 
1.06 (0.97,1.16) 
0.99 (0.89,1.10) 
 
1.00 
1.07 (0.91,1.25) 
1.04 (0.88,1.23) 
1.17 (0.97,1.41) 
 
1.00 
1.06 (0.93,1.22) 
1.25 (1.09,1.42) 
1.28 (1.10,1.49) 
Heavy periods 
Never (reference) 
Rarely 
Sometimes  
Often B,C 
 
1.00 
1.02 (0.92,1.13) 
0.96 (0.86,1.08) 
0.90 (0.77,1.05) 
 
1.00 
0.86 (0.73,1.02) 
0.82 (0.68,0.98) 
0.64 (0.49,0.82) 
 
1.00 
0.97 (0.89,1.06) 
0.91 (0.83,1.00) 
0.80 (0.70,0.91) 
 
1.00 
0.96 (0.82,1.14) 
0.85 (0.71,1.02) 
0.76 (0.60,0.95) 
 
1.00 
0.95 (0.83,1.10) 
1.00 (0.86,1.15) 
0.90 (0.75,1.09) 
Painful periods  
Never (reference) 
Rarely C 
Sometimes  
Often  
 
1.00 
0.99 (0.90,1.10) 
1.07 (0.95,1.21) 
0.98 (0.82,1.16) 
 
1.00 
1.01 (0.86,1.18) 
1.02 (0.84,1.24) 
1.38 (1.07,1.78) 
 
1.00 
1.13 (1.04,1.22) 
1.03 (0.94,1.14) 
1.09 (0.95,1.25) 
 
1.00 
1.13 (0.97,1.32) 
1.11 (0.92,1.32) 
1.30 (1.02,1.65) 
 
1.00 
0.98 (0.86,1.11) 
0.83 (0.71,0.96) 
1.13 (0.93,1.37) 
Time 
Survey 4 (reference) 
Survey 5 A,B,C,D 
Survey 6 A,B,C,D,E 
 
1.00  
1.20 (1.12,1.28) 
1.34 (1.25,1.43) 
 
1.00 
1.39 (1.24,1.57) 
1.65 (1.46,1.84) 
1.00 
1.15 (1.09,1.22) 
1.22 (1.15,1.29) 
1.00 
1.45 (1.28,1.63) 
1.48 (1.31,1.66) 
1.00 
0.91 (0.83,1.00) 
0.85 (0.78,0.94) 
 
A statistically significant association with chiropractor                                          D statistically significant association with acupuncturist 
 B statistically significant association with osteopath   E statistically significant association with naturopath/herbalist 
 C statistically significant association with massage therapist  
 
*Adjusted for co-morbidities of diabetes, hypertension, anaemia, asthma, depression, anxiety and cancer and for demographics of area of residence, marital status, educational status 
and ability to manage on income.  All models have a Wald statistic p value <0.005. 
 
 
Table 3. Prevalence of cyclic perimenstrual pain and discomfort symptom and use of complementary and alternative medicine 
practitioners in 2012. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Cyclic Perimenstrual 
Pain and Discomfort 
Symptom 
Chiropractor Osteopath 
 
Massage therapist Acupuncturist Naturopath/Herbalist 
No 
(n=5,980) 
Yes 
(n=1,493) 
No 
(n=6,849) 
Yes 
(n=624) 
No 
(n=4,305) 
Yes 
(n=3,168) 
No 
(n=6,799) 
Yes 
(n=674) 
No 
(n=6,628) 
Yes 
(n=845)  
 % % % % % % % % % % 
Endometriosis 
No 
Yes 
 
77.3 
2.8 
 
19.0 
0.9 
 
88.3 
3.3 
 
 
8.0 
0.4 
 
 
55.9 
1.8 
 
40.5 
1.9 
 
87.8 
3.1 
 
 
8.5 
0.6 
 
 
85.6 
3.0 
 
10.7 
0.7 
PMS  
Never 
Rarely 
Sometimes 
Often 
 
 
30.3 
16.7 
22.5 
10.5 
 
7.2 
4.4 
5.8 
2.6 
 
34.7 
19.3 
26.0 
11.6 
 
2.8 
1.8 
2.4 
1.4 
 
22.9 
12.0 
15.7 
6.9 
 
14.6 
9.1 
12.7 
6.1 
 
34.7 
19.2 
25.5 
11.6 
 
2.8 
1. 9 
2.8 
1.5 
 
34.2 
19.0 
24.9 
10.7 
 
3.2 
2.2 
3.5 
2.3 
Irregular Periods 
Never 
Rarely 
Sometimes 
Often 
 
 
49.0 
13.5 
10.3 
7.2 
 
12.3 
2.9 
3.0 
1.8 
 
56.0 
15.1 
12.3 
8.3 
 
5.3 
1.3 
1.0 
0.7 
 
35.4 
9.8 
7.1 
5.2 
 
25.9 
6.6 
6.2 
3.8 
 
56.0 
14.9 
12.1 
8.0 
 
5.2 
1.6 
1.2 
1.0 
 
55.0 
14.5 
11.5 
7.7 
 
6.2 
2.0 
1.8 
1.3 
Heavy Periods 
Never 
Rarely 
Sometimes 
Often 
 
42.4 
13.6 
15.0 
9.0 
 
10.3 
3.9 
3.5 
2.3 
 
48.1 
16.2 
16.9 
10.5 
 
4.5 
1.3 
1.6 
0.9 
 
30.4 
9.7 
10.6 
6.8 
 
22.2 
7.8 
7.9 
4.6 
 
48.0 
16.0 
16.8 
10.2 
 
4.7 
1.5 
1.7 
1.1 
 
47.4 
15.4 
16.2 
9.7 
 
5.2 
2.1 
2.3 
1.7 
Painful Periods 
Never 
Rarely 
Sometimes 
Often 
 
 
42.5 
17.9 
13.2 
6.3 
 
10.6 
4.7 
3.1 
1.7 
 
48.8 
20.8 
14.9 
7.2 
 
4.3 
1.8 
1.4 
0.8 
 
31.5 
12.4 
9.2 
4.5 
 
21.7 
10.3 
7.0 
3.4 
 
48.8 
20.5 
14.7 
7.0 
 
4.3 
2.1 
1.6 
1.0 
 
47.7 
19.9 
14.5 
6.6 
 
5.4 
2.8 
1.7 
1.4 
Table 4. The odds ratio* for association between cyclic perimenstrual pain and discomfort and use of complementary and alternative 
medicine therapies and products. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A statistically significant association with vitamins/minerals D statistically significant association with aromatherapy oils  
Bstatistically significant association with yoga or meditation E statistically significant association Chinese medicines       
Cstatistically significant association with herbal medicines  
 
*Adjusted for co-morbidities of diabetes, hypertension, anaemia, asthma, depression and anxiety and for demographics of area of residence, marital status, educational status, ability 
to manage on income, body-mass index, parity, stress, level of exercise, oral/implant contraceptive use and ethnicity. All models have a Wald statistic p value <0.005. 
 
**PMS (premenstrual syndrome) - the emotional, physical and behavioural changes that occur in the luteal phase of menstruation and which subside with the onset of, or 
after, menstruation.  
 
 
Cyclic Perimenstrual Pain 
and Discomfort Symptom 
 
Vitamins/minerals 
 
Yoga/meditation 
 
Herbal medicines 
 
Aromatherapy 
 
Chinese medicines 
 
Odds Ratio (C.I.) 
(n=9268) 
 
Odds Ratio (C.I.) 
(n=9267) 
 
Odds Ratio (C.I.) 
(n=9264) 
 
Odds Ratio (C.I.) 
(n=9264) 
 
Odds Ratio (C.I.) 
(n=9263) 
Endometriosis 
No (reference) 
YesA,B,C,E 
 
1.00 
1.43 (1.19,1.71) 
 
1.00 
1.33 (1.12,1.59) 
 
1.00 
1.34 (1.12,1.59) 
 
1.00 
1.12 (0.93,1.35) 
 
1.00 
1.98 (1.51,2.59) 
PMS**  
Never (reference) 
RarelyC, 
Sometimes,B,C,D 
Often A,B,C,D 
 
1.00 
0.96 (0.88,1.04) 
1.04 (0.95,1.13) 
1.21 (1.08,1.37) 
 
1.00 
1.08 (0.98,1.20) 
1.16 (1.05,1.28) 
1.27 (1.11,1.45) 
 
1.00 
1.21 (1.09,1.35) 
1.34 (1.21,1.49) 
1.49 (1.30,1.69) 
 
1.00 
1.09 (0.98,1.21) 
1.28 (1.15,1.41) 
1.27 (1.11,1.45) 
 
1.00 
1.17 (0.95,1.43) 
1.19 (0.98,1.45) 
1.32 (1.04,1.69) 
Irregular Periods  
Never (reference) 
Rarely  
Sometimes  
Often  
 
1.00 
1.08 (0.98,1.18) 
1.11 (1.00,1.23) 
1.10 (0.98,1.25) 
 
1.00 
0.98 (0.88,1.09) 
1.13 (1.01,1.27) 
1.02 (0.89,1.17) 
 
1.00 
1.03 (0.93,1.15) 
1.07 (0.95,1.20) 
1.08 (0.94,1.23) 
 
1.00 
1.04 (0.93,1.16) 
1.09 (0.98,1.23) 
0.95 (0.83,1.09) 
 
1.00 
1.04 (0.84,1.28) 
1.29 (1.05,1.59) 
1.21 (0.95,1.54) 
Heavy Periods  
Never (reference) 
Rarely 
Sometimes 
Often  
 
1.00 
1.02 (0.93,1.13) 
0.95 (0.86,1.06) 
0.91 (0.79,1.05) 
 
1.00 
1.01 (0.90,1.12) 
0.99 (0.88,1.12) 
0.85 (0.72,1.00) 
 
1.00 
0.97 (0.87,1.09) 
1.04 (0.92,1.17) 
1.05 (0.90,1.23) 
 
1.00 
0.97 (0.87,1.09) 
0.93 (0.83,1.05) 
0.91 (0.78,1.07) 
 
1.00 
1.01 (0.81,1.25) 
0.88 (0.70,1.10) 
0.84 (0.63,1.13) 
Painful Periods  
Never (reference) 
Rarely 
Sometimes 
Often D 
 
1.00 
0.90 (0.83,0.99) 
0.96 (0.86,1.07) 
0.96 (0.82,1.12) 
 
1.00 
0.97 (0.88,1.08) 
1.00 (0.89,1.13) 
1.24 (1.05,1.47) 
 
1.00 
0.97 (0.87,1.08) 
0.96 (0.85,1.09) 
1.19 (1.00,1.40) 
 
1.00 
1.02 (0.91,1.13) 
1.10 (0.97,1.24) 
1.33 (1.13,1.58) 
 
1.00 
1.07 (0.87,1.31) 
1.05 (0.83,1.33) 
1.47 (1.09,1.99) 
Time 
Survey 4 (reference) 
Survey 5 A,B,C,D.E 
Survey 6 A,B,D,E 
 
1.00 
1.21 (1.12,1.31) 
1.25 (1.15,1.36) 
 
1.00 
1.16 (1.06,1.27) 
1.20 (1.10,1.32) 
 
1.00 
1.18 (1.08,1.29) 
1.06 (0.97,1.17) 
 
1.00 
0.83 (0.76,0.91) 
0.70 (0.64,0.77) 
 
1.00 
1.63 (1.36,1.95) 
1.51 (1.26,1.81) 
Table 5. Prevalence of cyclic perimenstrual pain and discomfort symptom and use of complementary and alternative medicine  
therapies and products in 2012. 
 
 
 
 
 
Cyclic Perimenstrual 
Pain and Discomfort 
Symptom  
Vitamins/Minerals Yoga/Meditation 
 
Herbal medicines Aromatherapy oils Chinese medicines 
No 
(n=2,384) 
Yes 
(n=5,043) 
No 
(n=5,713) 
Yes 
(n=1,714) 
No 
(n=5,927) 
Yes 
(n=1,500) 
No 
(n=6,224) 
Yes 
(n=1,203) 
No 
(n=7,024) 
Yes 
(n=403) 
 % % % % % % % % % % 
Endometriosis 
No 
Yes 
 
 
31.2 
0.8 
 
65.1 
2.9 
 
74.5 
2.4 
 
21.8 
1.3 
 
77.1 
2.6 
 
19.2 
1.1 
 
80.8 
3.0 
 
15.5 
0.7 
 
91.2 
3.3 
 
5.1 
0.4 
PMS  
Never 
Rarely 
Sometimes 
Often 
 
 
13.1 
7.3 
8.3 
3.4 
 
24.3 
13.9    
20.1 
9.6 
 
29.9 
16.5 
21.4 
9.1 
 
7.5 
4.7 
7.1 
3.8 
 
31.6 
17.1 
21.9 
9.3 
 
5.8 
4.1 
6.5 
3.7 
 
32.7 
18.0 
23.0       
10.1 
 
4.7 
3.2 
5.4 
2.9 
 
35.7 
20.1 
26.8 
12.0 
 
1.6 
1.1 
1.7 
1.0 
Irregular Periods 
Never 
Rarely 
Sometimes 
Often 
 
 
20.6 
5.0 
3.8 
2.7 
 
40.6 
11.5 
9.6 
6.2 
 
47.4 
12.8 
9.8 
6.9 
 
13.9 
3.7 
3.5 
2.0 
 
49.8 
13.1 
10.1 
6.9 
 
11.4 
3.4 
3.2 
2.1 
 
51.9 
13.6 
11.0 
7.3 
 
9.3 
2.9 
2.4 
1.6 
 
58.3 
15.6 
12.4 
8.3 
 
2.9 
0.9 
0.9 
0.7 
Heavy Periods 
Never 
Rarely 
Sometimes 
Often 
 
 
17.6 
5.5 
5.6 
3.4 
 
35.0 
12.0 
12.9 
8.0 
 
40.8 
13.3 
14.1 
8.7 
 
11.8 
4.2 
4.5 
2.6 
 
43.2 
13.9 
14.4 
8.3 
 
9.4 
3.6 
4.1 
3.1 
 
45.0 
14.6 
15.0 
9.1 
 
7.6 
2.9 
3.5 
2.3 
 
49.9 
16.6 
17.6 
10.5 
 
2.7 
0.9 
1.0 
0.8 
Painful Periods 
Never 
Rarely 
Sometimes 
Often 
 
 
17.5 
7.6 
4.8 
2.1 
 
35.6 
15.1 
11.4 
5.9 
 
41.6 
17.4 
12.3 
5.7 
 
11.6 
5.2 
3.9 
2.3 
 
44.0 
17.9 
12.5 
5.5 
 
9.1 
4.8 
3.7 
2.5 
 
45.9 
19.0 
12.9 
6.0 
 
7.2 
3.6 
3.4 
2.0 
 
50.6 
21.4 
15.3 
7.3 
 
2.5 
1.3 
0.9 
0.7 
